Cancer immunotherapy
A special series of articles discussing the opportunities and challenges for cancer immunotherapy.
Index
Top of page
Top of page
2015
September 2015 Volume 14 No 9
Big opportunities for small molecules in immuno-oncology
Jerry L. Adams, James Smothers, Roopa Srinivasan & Axel Hoos
doi:10.1038/nrd4596
September 2015 Volume 14 No 9
Oncolytic viruses: a new class of immunotherapy drugs
Howard L. Kaufman, Frederick J. Kohlhapp & Andrew Zloza
doi:10.1038/nrd4663
August 2015 Volume 14 No 8
Combination cancer immunotherapy and new immunomodulatory targets
Kathleen M. Mahoney, Paul D. Rennert & Gordon J. Freeman
doi:10.1038/nrd4591
July 2015 Volume 14 No 7
Therapeutic approaches to enhance natural killer cell cytotoxicity against cancer: the force awakens
Richard W. Childs & Mattias Carlsten
doi:10.1038/nrd4506
July 2015 Volume 14 No 7
The pharmacology of second-generation chimeric antigen receptors
Sjoukje J. C. van der Stegen, Mohamad Hamieh & Michel Sadelain
doi:10.1038/nrd4597